After reducing its footprint in Connecticut in recent years, pharmaceutical giant McKesson Corp. plans to close one of its last remaining locations in the state.
A company spokesman confirmed the maker of medical supplies will move its operations from a Farmington office building at 1690 New Britain Ave., operated by subsidiary Moore Medical LLC, to other McKesson locations across the U.S. before June 2020.
The consolidation will leave almost 150 people without jobs. Employees will be able to apply for any of McKesson’s more than 700 job openings nationwide, he said.
McKesson in recent years has moved its Southington and Rocky Hill operations out of Connecticut to other U.S. locations. A transportation facility in North Haven is its last remaining footprint in Connecticut, the spokesman said.
The distributor, which relocated its headquarters from San Francisco to Irving, Texas this year, has also been sued by New Britain, Wallingford, New Haven and other municipalities for its alleged influence fueling the opioid epidemic by inflating drug prices and lacking oversight of opioid shipments.
[Read more: Authorities in 39 states investigate opioid industry]
In 2010, McKesson agreed to a $15 million settlement with the state of Connecticut for artificially inflating drug costs for over 400 brand name drugs.
The company, which employs about 8,000 employees nationwide, generated more than $208 billion in revenue in 2018. The company generated the seventh most revenue in the U.S. last year, according to Fortune magazine.
